TRPV2 and hepatocellular carcinoma: As mentioned earlier, CBD promotes doxorubicin uptake in hepatocellular carcinoma (BNL1) cells by activating the TRPV2 channel, thereby facilitating doxorubicin-mediated cell death [11].